The main market opportunities arise from enhancing supply chain integrity in the pharmaceutical industry through GDP and GSP compliance. This addresses regulatory adherence, quality assurance, and ...
Key market opportunities include enhancing quality systems in the pharmaceutical supply chain, robust implementation of Good Distribution Practice (GDP), and combating counterfeit drug threats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results